IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptR-TXSource pending

Roger Williams disclosed SELL $PFE

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$1K – $15K
Filed
2024-06-12
Trade date
2024-03-04
Disclosure lag
100 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Source pending
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 100 days after the trade date, beyond the standard 45-day STOCK Act window.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
418 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Roger Williams, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Market context is shown as a post-trade reference (-51.7% versus SPY); it is not a trading recommendation.

Source

source pending
Source: indexed congressional disclosure; official source link pending · filed 2024-06-12 · disclosed 100d after transaction

Market context

Pfizer Inc.

Sector: Healthcare

Vs SPY: -51.7%

Factual flags

  • Filed after the standard 45-day STOCK Act window.
  • 18 nearby same-ticker disclosures in the surrounding 30-day window.
  • Filed 100 days after the reported transaction date (standard disclosure window: 45 days).

Member trail

Roger Williams

U.S. House · TX-25

House Committee on Financial ServicesHouse Committee on Small Business

Ticker trail

$PFE

Pfizer Inc.

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.